Diagnostic Accuracy of MRI and Additional [ 18 F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
Background: Neuroimaging has a reasonable accuracy to differentiate behavioral variant frontotemporal dementia (bvFTD) from other neurodegenerative disorders, its value for the differentiation of bvFTD among subjects with acquired behavioral disturbances is unknown. Objective: To determine the diagnostic accuracy of MRI, additional [ 18 F]FDG-PET, and their combination for bvFTD among subjects with late onset behavioral changes. Methods: Patients with late onset behavioral changes referred to a memory clinic or psychiatric services were included. At baseline, 111 patients had a brain MRI scan and 74 patients received an additional [ 18 F]FDG-PET when the MRI was inconclusive. The consensus diagnosis after two-year-follow-up was used as the gold standard to calculate sensitivity and specificity for baseline neuroimaging. Results: 27 patients had probable/definite bvFTD and 84 patients had a non-bvFTD diagnosis (primary psychiatric diagnosis or other neurological disorders). MRI had a sensitivity of 70% (95% CI 52–85%) with a specificity of 93% (95% CI 86–97%). Additional [ 18 F]FDG-PET had a sensitivity of 90% (95% CI 66–100%) with a specificity of 68% (95% CI 56–79%). The sensitivity of combined neuroimaging was 96% (95% CI 85–100%) with a specificity of 73% (95% CI 63–81%). In 66% of the genetic FTD cases, MRI lacked typical frontotemporal atrophy. 40% of cases with a false positive [ 18 F]FDG-PET scan had a primary psychiatric diagnosis. Conclusion: A good diagnostic accuracy was found for MRI and additional [ 18 F]FDG-PET for bvFTD in patients with late onset behavioral changes. Caution with the interpretation of neuroimaging results should especially be taken in cases with a genetic background and in cases with a primary psychiatric differential diagnosis where [ 18 F]FDG-PET is the only abnormal investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 1×
“Cognitive screening tests included the Mini-Mental State Examination (MMSE) [21] and the Frontal Assessment Battery (FAB) [22].”
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · cited 1×
“Psychiatric evaluation included applying the Montgomery Aberg Depression Rating Scale (MADRS) [23] for depressive symptoms, the positive and negative symptom scale for psychotic symptoms (PANSS) [24], and the MINI-PLUS Diagnostic interview [25] to assess primary psychiatric disorders.”
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · cited 1×
“Diagnoses were based on the published consensus guidelines for dementia and the primary psychiatric diagnoses were based on current psychiatric criteria [4, 29–33].”
Self-citationA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 1×
“Psychiatric evaluation included applying the Montgomery Aberg Depression Rating Scale (MADRS) [23] for depressive symptoms, the positive and negative symptom scale for psychotic symptoms (PANSS) [24], and the MINI-PLUS Diagnostic inter-view [25] to assess primary psychiatric disorders.”
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging
Fazekas, F., Chawluk, J., Alavi, A., Hurtig, H., & Zimmerman, R. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,334
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 2×
“As described in the international consensus criteria for bvFTD (FTDC), the presence of frontotemporal abnormalities on neuroimaging is considered as a biomarker for bvFTD, and is mandatory for the diagnosis probable bvFTD [4].”
Self-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141 · cited 1×
“Diagnoses were based on the published consensus guidelines for dementia and the primary psychiatric diagnoses were based on current psychiatric criteria [4, 29–33].”
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Research works printed but not linked: 2
- American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders 4th edition Text Revision (DSM-IV-TR) American Psychiatric Association Washington DC.
- 10.1159/000100973 · DOI · Paper page
Cited by
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Amsterdam Dementia Cohort: Performing Research to Optimize Care
van der Flier, W. M., & Scheltens, P. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170850 · Cited by 390
Self-citationDucharme, S., Dols, A., Laforce, R., Devenney, E., Kumfor, F., van den Stock, J., Dallaire-Théroux, C., Seelaar, H., Gossink, F., Vijverberg, E., et al. (2020) · Brain · doi:10.1093/brain/awaa018 · Cited by 320
Self-citationBoeve, B. F., Boxer, A. L., Kumfor, F., Pijnenburg, Y., & Rohrer, J. D. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00341-0 · Cited by 218
Self-citationImaging and fluid biomarkers in frontotemporal dementia
Meeter, L. H., Kaat, L. D., Rohrer, J. D., & van Swieten, J. C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.75 · Cited by 210
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Chouliaras, L., & O’Brien, J. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02215-8 · Cited by 221
“Conditions such as PSP, autoimmune encephalitis, chronic schizophrenia, alcohol related brain damage and late onset psychiatric disorders [137 – 139] may also be associated with patterns of frontal hypometabolism on FDG-PET and therefore FDG-PET should be used in combination with history and other…”
BackgroundFrontotemporal Dementia, Where Do We Stand? A Narrative Review
Antonioni, A., Raho, E. M., Lopriore, P., Pace, A. P., Latino, R. R., Assogna, M., Mancuso, M., Gragnaniello, D., Granieri, E., Pugliatti, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411732 · Cited by 145
“Brain magnetic resonance imaging (MRI) and 18F-fluoro-2-deoxyglucose positron emission tomography ([18F]FDG-PET) scans together have a sensitivity of 96% and a specificity of 73% [147].”
BackgroundStaffaroni, A., Elahi, F., McDermott, D., Marton, K., Karageorgiou, E., Sacco, S., Paoletti, M., Caverzasi, E., Hess, C., Rosen, H., et al. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608808 · Cited by 91
Psychiatric Presentations of C9orf72 Mutation: What Are the Diagnostic Implications for Clinicians?
Ducharme, S., Bajestan, S., Dickerson, B. C., & Voon, V. (2017) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.16090168 · Cited by 84
Krudop, W. A., Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., et al. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170608 · Cited by 57
“Diagnostic quality of imaging for bvFTD within the total LOF-cohort has been prospectively studied in more detail showing a sensitivity of 70% and a specificity of 93% for MRI and a sensitivity of 90% and a specificity of 68% for [ 18 F]FDG-PET [48].”
Self-citationFTD spectrum: Neuroimaging across the FTD spectrum
Whitwell, J. L. (2019) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2019.05.009 · Cited by 53
McCarthy, J., Collins, D. L., & Ducharme, S. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.08.028 · Cited by 47
Vijverberg, E. G. B., Dols, A., Krudop, W. A., Del Campo Milan, M., Kerssens, C. J., Gossink, F., Prins, N. D., Stek, M. L., Scheltens, P., Teunissen, C. E., et al. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.009 · Cited by 46
“This results in a similar or even higher diagnostic accuracy for bvFTD than frontotemporal changes on neuroimaging [4,37,38].”
BackgroundResultSelf-citationDucharme, S., Pearl-Dowler, L., Gossink, F., McCarthy, J., Lai, J., Dickerson, B. C., Chertkow, H., Rapin, L., Vijverberg, E., Krudop, W., et al. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180839 · Cited by 42
Self-citationNeuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis
Häkkinen, S., Chu, S. A., & Lee, S. E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105063 · Cited by 43
“…et al., 2017a; Diehl-Schmid et al., 2007; Morbelli et al., 2016; Tosun et al., 2016; Verfaillie et al., 2015; Vijverberg et al., 2016), yet frontal hypometabolism has also been reported in psychiatric disorders and Alzheimer's disease, which confounds diagnostic accuracy (Vijverberg et al., 2016).”
BackgroundFrontotemporal Dementia – Current Concepts
Puppala, G. K., Gorthi, S. P., Chandran, V., & Gundabolu, G. (2021) · Neurology India · doi:10.4103/0028-3886.329593 · Cited by 44
Gossye, H., Van Broeckhoven, C., & Engelborghs, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00757 · Cited by 34
“For FTD, the sensitivity of FDG PET scan ranges from 47 to 90%; the specificity from 68 to 98% (Foster et al., 2007; Kerklaan et al., 2014; Vijverberg et al., 2016).”
BackgroundInfluentialNon-coding RNAs and neuroinflammation: implications for neurological disorders
Chen, Y., Mateski, J., Gerace, L., Wheeler, J., Burl, J., Prakash, B., Svedin, C., Amrick, R., & Adams, B. D. (2024) · Experimental Biology and Medicine · doi:10.3389/ebm.2024.10120 · Cited by 32
Pressman, P. S., Matlock, D., & Ducharme, S. (2021) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.20090238 · Cited by 30
Dual-phase [18F]florbetapir in frontotemporal dementia
Asghar, M. B., Hinz, R., Herholz, K., & Carter, S. F. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4238-2 · Cited by 31
Najafpour, Z., Fatemi, A., Goudarzi, Z., Goudarzi, R., Shayanfard, K., & Noorizadeh, F. (2020) · Journal of Neuroradiology · doi:10.1016/j.neurad.2020.12.003 · Cited by 26
Recent Advances in Frontotemporal Dementia
Tartaglia, M. C., & Mackenzie, I. R. (2022) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2022.69 · Cited by 27
Na, S., Kang, D. W., Kim, G. H., Kim, K. W., Kim, Y., Kim, H.-J., Park, K. H., Park, Y. H., Byeon, G., Suh, J., et al. (2024) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2024.23.1.54 · Cited by 28
“12,20,21,25 The National Institute for Health and Care Excellence guidelines of dementia assessment, 26 the Canadian Consensus Conferences on the Diagnosis and Treatment of Dementia, 27 and the European Federation of the Neurological Societies (EFNS) guideline 3 for the use of neuroimaging in…”
InfluentialMRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia
Manera, A. L., Dadar, M., Van Swieten, J. C., Borroni, B., Sanchez-Valle, R., Moreno, F., Laforce Jr, R., Graff, C., Synofzik, M., Galimberti, D., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324106 · Cited by 23
“and 93% specificity have been reported for structural MRI alone for bvFTD assessed by an experienced neuroradiologist.(8) The latter results have comparable positive and negative likelihood”
BackgroundFrontotemporal dementia. How to deal with its diagnostic complexity?
Antonioni, A., Raho, E. M., Granieri, E., & Koch, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2461758 · Cited by 25
“Importantly, as noted above, although detection of a suggestive atrophy pattern is rather specific, it is not very sensitive, particularly in the early stages, leading to misdiag-nosis or delayed diagnosis [392].”
Frontotemporal Dementia and Late-Onset Bipolar Disorder: The Many Directions of a Busy Road
da Silva, M. N. M., Porto, F. H. D. G., Lopes, P. M. G., Prado, C. S. D. C., Frota, N. A. F., Alves, C. H. L., & Alves, G. S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.768722 · Cited by 22
“Thus, systematic psychiatric follow-up reevaluation of suspected bvFTD—in a minimal period of 2 years–is required in most cases to ensure and validate the baseline molecular findings (39).”
BackgroundInfluentialZhutovsky, P., Vijverberg, E. G. B., Bruin, W. B., Thomas, R. M., Wattjes, M. P., Pijnenburg, Y. A. L., van Wingen, G. A., & Dols, A. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181004 · Cited by 20
Self-citationPET Imaging in Psychiatric Disorders
Ferrando, R., Hernandes, D., Ghini, B. G., & Coutinho, A. M. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.06.004 · Cited by 20
Brzezicki, M. A., Kobetić, M. D., Neumann, S., & Pennington, C. M. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.03.002 · Cited by 19
“An addition of a multivariate analysis [22] or a PET scan may improve the accuracy [23,24], albeit only to a limited extent [25].”
BackgroundNavigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics
Abiad, E. E., Al-Kuwari, A., Al-Aani, U., Jaidah, Y. A., & Châari, A. (2024) · Cells · doi:10.3390/cells13221901 · Cited by 21
“For instance, cortical thinning observed in MRI scans may be caused by other medical conditions, while amyloid plaques, detected through PET scans, can also appear in individuals without AD, leading to inaccurate diagnoses [12,13].”
Frontotemporal dementia subtyping using machine learning, multivariate statistics and neuroimaging
Metz, A., Zeighami, Y., Ducharme, S., Villeneuve, S., & Dadar, M. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf065 · Cited by 22
“…Structural magnetic resonance imaging (MRI) is commonly used in clinical practice to confirm a diagnosis of FTD. 11 However, classical MRI metrics are currently insufficiently sensitive to detect subtle neuronal loss in the early stages of the disease, 12 leading to delayed or incorrect diagnoses.”
Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration
Duignan, J. A., Haughey, A. M., Kinsella, J. A., & Killeen, R. P. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.002 · Cited by 18
Neuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility
Dev, S. I., Dickerson, B. C., & Touroutoglou, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_7 · Cited by 18
Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
Ducharme, S., Pijnenburg, Y. A. L., Rohrer, J. D., Huey, E. D., Finger, E. C., & Tatton, N. A. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.08.017 · Cited by 22
“7,109 Recent clinical practice recommendations to guide the differential diagnosis of bvFTD vs PPD suggest various approaches to improve diagnostic accuracy, such as the inclusion of at least 1 structured test of social cognition (e.g., Ekman 60 Faces Test, Social Cognition and Emotional Assessment…”
BackgroundSelf-citationDiagnostic Instability Over Time in the Late-Onset Frontal Lobe Syndrome: When Can We Say it's FTD?
de Boer, S. C. M., Gossink, F., Krudop, W., Vijverberg, E., Schouws, S., Reus, L. M., Pijnenburg, Y. A. L., & Dols, A. (2023) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.02.006 · Cited by 15
Self-citationvan Engelen, M. E., Verfaillie, S. C. J., Dols, A., Oudega, M. L., Boellaard, R., Golla, S. S. V., den Hollander, M. E., Ossenkoppele, R., Scheltens, P., van Berckel, B. N. M., et al. (2023) · EJNMMI Research · doi:10.1186/s13550-023-01020-2 · Cited by 14
“In a previous study, we found that 33% of PPD with late-onset behavioural symptoms had a falsepositive [18F]FDG PET scan for bvFTD, resulting in a low specificity (68%) [6].”
BackgroundSelf-citationDas, S., van Engelen, M.-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E., & Verberk, I. M. W. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01409-8 · Cited by 12
“This leads to misdiagnosis in 50% of the cases with an average diagnostic delay of 6.4 years [3–5].”
BackgroundInfluentialSelf-citationKrishnadas, N., Chew, M., Sutherland, A., Christensen, M., Rogers, K., Kyndt, C., Islam, F., Darby, D., & Brodtmann, A. G. (2024) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200360 · Cited by 13
Cagnin, A., Pigato, G., Pettenuzzo, I., Zorzi, G., Roiter, B., Anglani, M. G., Bussè, C., Mozzetta, S., Gabelli, C., Campi, C., et al. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.01.015 · Cited by 11
“…on clinical manifestations of a frontal lobe syndrome, recent diagnosis of a late-onset primary psychiatric disorder, and absent or minimal frontal lobe atrophy or hypo-metabolism, according to previous studies by Vijverberg and collaborators (Vijverberg et al., 2016; Vijverberg et al., 2017).”
BackgroundResultInfluentialMa, D., Stocks, J., Rosen, H., Kantarci, K., Lockhart, S. N., Bateman, J. R., Craft, S., Gurcan, M. N., Popuri, K., Beg, M. F., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1331677 · Cited by 9
Dissecting the Many Faces of Frontotemporal Dementia: An Imaging Perspective
Pengo, M., Premi, E., & Borroni, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112867 · Cited by 11
“Low glucose metabolism is observed in comparable brain structures, mainly in the orbitofrontal, dorsolateral and medial prefrontal cortices, anterior temporal poles and basal ganglia [39,49,50].”
BackgroundDavydow, D. S., Brasfield, M., Morrow, C. B., Staffaroni, A. M., Pontone, G. M., & Asken, B. M. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.2429 · Cited by 9
Levy, J. P., Bocti, C., Élie, D., Paquet, N., Soucy, J., & Ducharme, S. (2018) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.18050114 · Cited by 9
van Engelen, M. E., Rozemüller, A. J. M., Erkoyun, H. U., Groot, C., Fieldhouse, J. L. P., Koene, T., Ossenkoppele, R., Gossink, F. T., Krudop, W. A., Vijverberg, E. G. B., et al. (2021) · Neurocase · doi:10.1080/13554794.2021.1905855 · Cited by 8
Self-citationCurrent role of 18F-FDG-PET in the differential diagnosis of the main forms of dementia
Guillén, E. F., Rosales, J. J., Coscia, D. L., Grisanti, F., Riverol, M., & Arbizu, J. (2020) · Clinical and Translational Imaging · doi:10.1007/s40336-020-00366-0 · Cited by 7
Calloni, S. F., Vezzulli, P. Q., Castellano, A., Leone, R., Basaia, S., von Loon, A., Spinelli, E. G., Magnani, G., Caso, F., Agosta, F., et al. (2023) · Neuroradiology · doi:10.1007/s00234-023-03133-w · Cited by 6
Soni, N., Ora, M., Bathla, G., Nagaraj, C., Ponto, L. L. B., Graham, M. M., Saini, J. S., & Menda, Y. (2021) · The Neuroradiology Journal · doi:10.1177/1971400921998968 · Cited by 10
“To differentiate bvFTD from other NDDs, the addition of FDG-PET information to sMRI increases sensitivity from 70% to 96%, albeit with lower specificity (73% from 93%).(63) FDG-PET based anterior DMN integrity accurately differentiated bvFTD and AD patients with higher accuracy (94%), supporting metabolic connectivity…”
BackgroundGambogi, L. B., de Souza, L. C., & Caramelli, P. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2022-s140 · Cited by 7
Raji, C. A., Meysami, S., Porter, V. R., Merrill, D. A., & Mendez, M. F. (2024) · BMC Neurology · doi:10.1186/s12883-024-03844-4 · Cited by 5
“For bvFTD, visual evaluations in one study had a sensitivity of 70% and specificity of 93% [29].”
MethodBattista, M. E. D., Dell’Acqua, C., Baroni, L., Fenoglio, C., Galimberti, D., & Gallucci, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180524 · Cited by 5
Fesharaki‐Zadeh, A., Çayır, S., Ibrahim, W., Yang, Y., Gallezot, J., Naganawa, M., Wu, Y., Toyonaga, T., Sadabad, F. E., O’Dell, R. S., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71283 · Cited by 4
“7,9,10 Characteristic frontal and anterior temporal hypometabolism observed via 18 F-FDG PET can also aid in distinguishing bvFTD from AD.”
Gossink, F. T., Vijverberg, E. G. B., Pijnenburg, Y. A. L., & Dols, A. (2018) · Journal of Neuropsychiatry · doi:10.21767/2471-8548.10004 · Cited by 4
“The additional [18F]FDG-PET, when the MRI was inconclusive, had a sensitivity of 90% at the cost of a lower specificity (68%) [16].”
BackgroundSelf-citationDubey, S., Dubey, M. J., Ghosh, R., Mukherjee, D., Pandit, A., & Benito‐León, J. (2022) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-022-00538-x · Cited by 6
“Executive dysfunctions have been claimed to be due to the involvement of the dorsolateral prefrontal cortex [15, 16].”
BackgroundInfluentialVentRa: distinguishing frontotemporal dementia from psychiatric disorders
Manera, A. L., Dadar, M., Ducharme, S., & Collins, D. L. (2024) · Brain Communications · doi:10.1093/braincomms/fcae069 · Cited by 3
“20,21 It is hypothesized that volumetric MRI could improve this sensitivity rate; however, there is insufficient evidence currently to formally recommend volumetric analytic techniques in clinical populations with behavioural changes.”
BackgroundMajor depression mistaken as frontotemporal dementia due to PET scan
Bystad, M. K., Grønli, O., & Wynn, R. (2024) · JRSM Open · doi:10.1177/20542704241241113 · Cited by 3
Chronic apathy following a major depressive episode: What is it?
Morin, A., Bernard, J., Carle, G., Ponchel, A., Azuar, C., Uggocioni, G., Mauras, T., Bendetowicz, D., Camus, M., Delcul, A., et al. (2025) · Cortex · doi:10.1016/j.cortex.2025.04.008 · Cited by 3
Neuropsychiatric symptoms in behavioral variant frontotemporal dementia: a narrative review
Page, J., Pontone, G. M., & Davydow, D. S. (2025) · International Review of Psychiatry · doi:10.1080/09540261.2025.2583257 · Cited by 3
“Yet, structural MRI may be insensitive while older adults with psychiatric disorders can demonstrate decreased cerebral metabolism on FDG-PET (Vijverberg et al., 2016).”
Delvecchio, G., Maggioni, E., Squarcina, L., Arighi, A., Galimberti, D., Scarpini, E. A., Bellani, M., & Brambilla, P. (2020) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-020-00204-7 · Cited by 3
Rue, I., Jones, S. L., de Boer, S. C. M., Soltaninejad, M., Diehl‐Schmid, J., Galimberti, D., Arighi, A., Halliday, G. M., Landín-Romero, R., Piguet, O., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13467-5 · Cited by 2
“Our cohort only includes patients with a final diagnosis of bvFTD and late onset PPD, whereas the Late Onset Frontal Lobe (LOF) study prospectively included patients with a diverse presentation of behavioral changes [21].”
InfluentialSelf-citationClinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset
Losa, M., Garbarino, S., Cirone, A., Argenti, L., Lombardo, L., Calizzano, F., Girtler, N. G., Brugnolo, A., Mattioli, P., Bauckneht, M., et al. (2025) · Cortex · doi:10.1016/j.cortex.2025.01.011 · Cited by 2
Frontal Hypometabolism in Neurocognitive Disorder with Behavioral Disturbance
Bastin, C., Bahri, M. A., Bernard, C., Hustinx, R., & Salmon, É. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.260497 · Cited by 2
“Among the differential diagnoses, frontal hypometabolism can be observed in schizophrenia, depression, or alcohol abuse for example (10,11).”
BackgroundFrontotemporal Dementia: A Clinical Review
Dacka, M., Porzak, M., Bochyński, K., Białogłowski, K., Dąbrowska, P., Żuber, M., Ciuba, K., Molenda, K., Borodziuk, F., & Borodziuk, B. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.59.015 · Cited by 3
Subramanyam, P., & Palaniswamy, S. S. (2024) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001942 · Cited by 1
“[11] reported that performing a standard MRI with visual review of images, however, may be deficient in sensitivity and specificity (70”
Ioannidis, S., Konstantinidou, N., Giannakis, A., Sioka, C., & Ioannidis, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010090 · Cited by 1
“…aforementioned clinical overlap between bvFTD and PPD, may negatively affect the diagnostic accuracy of neuroimaging in bvFTD. Vijverberg et al. [62], in 2016, studied and determined the diagnostic accuracy of MRI, adjunctive 18F FDG–PET, and their combination in a heterogeneous population with…”
18F-fluorodeoxyglucose PET in Major Psychiatric Disorders
Ferrando, R., & Coutinho, A. M. (2026) · PET Clinics · doi:10.1016/j.cpet.2026.05.007 · Cited by 1
Li, H., Zhang, X., Yao, M., Li, T., Pan, G., & Wang, H. (2026) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2026.100273 · Cited by 1
Brain atrophy patterns in patients with frontotemporal dementia: voxel-based morphometry
Akhmadullina, D. R., Коновалов, Р. Н., Shpilyukova, Y. A., Гришина, Д. А., Berdnikovich, E. S., Фоменко, С. С., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2020.075 · Cited by 1
“According to a number of reports, the accuracy of MRI in diagnosis of bvFTD varies between 59– 70% [9, 10].”
BackgroundBehavioural variant frontotemporal dementia – selected diagnostic dilemmas in neuropsychiatry
Oddział Psychogeriatryczny, S. D. N. I. P. C. W. S. G., Kuklińska, M., Sitek, E. J., Oddział Neurologii, S. S. Ś. W., Brockhuis, B., Barczak, A. K., Zakład Badawczo-Leczniczy Chorób Zwyrodnieniowych CUN, I. M. D. I. K. I. M. M., Oddział Alzheimerowski, K. N., Hintze, B., Zakład Psychologii Klinicznej Człowieka Dorosłego, A. P. S. I. M. G., et al. (2020) · Aktualności Neurologiczne · doi:10.15557/an.2020.0010 · Cited by 1
IRM encéphalique : quelle place dans le bilan des maladies neurologiques à expression cognitive ?
Pariente, J., Gouilly, D., Rafiq, M., Carlier, J., Tisserand, C., Rigal, É., Albucher, J., Danet, L., Planton, M., Bonneville, F., et al. (2021) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2021.03.010 · Cited by 1
Behavioral Variant Frontotemporal Dementia
Ford, J. N., & Chiang, G. C.-Y. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_26 · Cited by 2
Nuclear Imaging in Frontotemporal Dementia
Reesink, F. E., Stormezand, G. N., Dierckx, R. A. J. O., & Deyn, P. P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_15 · Cited by 3
Clinical considerations regarding suspected “BvFTD-by-proxy”: a case series
Weinhold, E. R., Vaughan, C. L., O’Hara, M., Bloemen, E. M., Bakeman, D. D., Ducharme, S., & Pressman, P. (2024) · Neurocase · doi:10.1080/13554794.2024.2419177 · Cited by 1
“These criteria distinguish bvFTD from Alzheimer’s disease with high accuracy but are less reliable at distinguishing bvFTD from primary psychiatric disorders (Krudop et al., 2017; Vijverberg et al., 2016).”
Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
Prinse, F., Houwer, J. F. H. D., Dopper, E. G. P., & Seelaar, H. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_9 · Cited by 1
Frontotemporal Lobar Degeneration
Filippi, M., & Agosta, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-66773-3_3 · Cited by 2
Akhmadullina, D. R., Коновалов, Р. Н., Шпилюкова, Ю. А., Гришина, Д. А., Бердникович, Е. С., Фоменко, С. С., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Вестник Российского государственного медицинского университета · doi:10.24075/vrgmu.2020.075
Voxel-Based Morphometry in Frontotemporal Dementia
Akhmadullina, D. R., Shpilyukova, Y. A., Коновалов, Р. Н., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Human Physiology · doi:10.1134/s0362119720080137
Manera, A. L., Dadar, M., Ducharme, S., & Collins, D. L. (2022) · SSRN Electronic Journal · doi:10.1101/2022.03.29.22273096
Affections apparentées à la maladie d’Alzheimer
Julian, A. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-76331-1.00013-6
Biomarkers based on neuroimages to diagnose neurodegenerative diseases
Reyes, P. A. (2020) · Repositorio Institucional (Pontificia Universidad Javeriana) · doi:10.11144/javeriana.10554.44894 · Cited by 1
(2018) · Elsevier eBooks · doi:10.1016/b978-0-323-52484-1.50072-8
Major Neurocognitive Disorders Due to Frontotemporal Disease
Gopalakrishna, G., Sarangi, A., & Joshi, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_4
Quantifying metabolic decrement in brain FDG-PET of a complex frontotemporal dementia case
Tuma, R. D. L. E., Coutinho, A. M., Carneiro, C. D. G., Cassimiro, L., de Souza, L. A. S., Buchpiguel, C. A., Takada, L. T., & Brucki, S. M. D. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-0277 · Cited by 1
“Psychiatric disorders can also present with metabolic abnormalities 20 , adding to the complexity of interpreting imaging studies with less pronounced changes.”
Das, S., van Engelen, M.-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E., & Verberk, I. M. W. (2024) · Figshare · doi:10.6084/m9.figshare.25223556
Self-citationvan Engelen, M.-P. E., Verfaillie, S. C. J., Dols, A., Oudega, M. L., Boellaard, R., Golla, S. S. V., den Hollander, M., Ossenkoppele, R., Scheltens, P., van Berckel, B. N. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23788259
Self-citationDas, S., van Engelen, M.-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E., & Verberk, I. M. W. (2024) · Figshare · doi:10.6084/m9.figshare.25223869
Self-citationRaji, C. A., Meysami, S., Porter, V. R., Merrill, D. A., & Mendez, M. F. (2024) · Figshare · doi:10.6084/m9.figshare.27000712
Early regional hypometabolism in presymptomatic MAPT carriers : a GENFI sub-study
St-Onge, F. (2019) · Corpus Université Laval (Université Laval)
Rue, I. (2025) · eScholarship@McGill (McGill) · doi:10.82308/50502
Dementias and Mild Cognitive Impairment in Adults
Boscarino, J. J., Maietta, J. E., Schoenberg, M. R., & Duff, K. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-07777-6_15
Gérolymos, C., Boudier, I., Eschallier, L., & Hinsinger, G. (2026) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2026.100337
Fumagalli, G., Fornari, C., de Boer, S. C. M., Fenoglio, C., Arighi, A., Riedl, L., Landín-Romero, R., Matis, S., Rue, I., Chatterton, Z., et al. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03223-y · Cited by 1
“This is especially frequent in the early stages of the disease, when atrophy may not be extensive and so not yet distinguishable from the age-related volumetric changes with standard visual radiological inspection of images (Vijverberg et al. 2016, Chow et al. 2008, Gregory et al. 1999 ).”
Self-citationFlavell, J., Shaw, T. B., Logan, B., Ahern, E. G. M., McElligott, C. A. T., & Nestor, P. J. (2026) · European Journal of Radiology · doi:10.1016/j.ejrad.2026.113128
Metadata
- Authors
- Vijverberg, E. G. B., Wattjes, M. P., Dols, A., Krudop, W. A., Möller, C., Peters, A., Kerssens, C. J., Gossink, F., Prins, N. D., Stek, M. L., Scheltens, P., van Berckel, B. N. M., Barkhof, F., & Pijnenburg, Y. A. L.
- Affiliations
- Amsterdam Neuroscience (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- GGZ inGeest (NL)
- Leiden University (NL)
- Department of Nuclear Medicine & PET research, VU University Medical Centre, Amsterdam, The Netherlands
- Corresponding author
- Vijverberg, Everard G.B.
- ORCID
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-06-30
- Volume
- 53
- Issue
- 4
- Pages
- 1287-1297
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2505161130
- Cited by
- 92
- References
- 53
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 18 · 2023: 7 · 2022: 7 · 2021: 14 · 2020: 11 · 2019: 5 · 2018: 8 · 2017: 6
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Vanderbilt University Medical Center
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- behavioral variant frontotemporal dementia, diagnostic accuracy
- MeSH terms
- Aged, Atrophy, Mental Disorders, Brain, False Negative Reactions, False Positive Reactions, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Sensitivity and Specificity, Age of Onset, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography, Frontotemporal Dementia, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.